Upregulation of Parathyroid Hormone Receptor 1 (PTH1R) in Non-Mechanostimulated Osteocytes Under High-Glucose Conditions Promotes a Macrophage Pro-Inflammatory and Osteoclastogenic Phenotype via IL-6 Secretion
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27041677 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Irene Tirado-Cabrera und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bone Physiopathology Laboratory, Instituto de Medicina Molecular Aplicada (IMMA), School of Medicine, Universidad San Pablo-CEU, CEU Universities, Ur…. Hauptthemen laut MEDLINE: Receptor, Parathyroid Hormone, Type 1, Interleukin-6, Osteocytes, Glucose. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia Innovación y Universidades, Sociedad y Fundación Española de Investigación Ósea y de Metabolismo Mineral, SEIOMM/FEIOMM, “Ministerio de Ciencia Innovación y Universidades”.
Abstract (Originalsprache)
Diabetes mellitus disrupts bone homeostasis, inducing bone fragility, through mechanisms involving chronic inflammation and altered cellular signaling. Osteocytes, the primary mechanosensory cells in bone, play a pivotal role in regulating bone remodeling via the secretion of factors that influence both osteoclast and osteoblast activity. We investigated the impact of high glucose on osteocytic parathyroid hormone receptor type 1 (PTH1R) expression and its downstream effects on interleukin-6 (IL-6) secretion, macrophage polarization, and osteoclastogenesis. Using both in vitro and ex vivo bone models, we demonstrate that elevated glucose levels in static conditions without mechanical stimulation induce the overexpression of PTH1R in osteocytes. PTH1R upregulation in turn enhances osteocytic IL-6 secretion associated with the promotion of a pro-inflammatory macrophage M1 phenotype (increased tumor necrosis factor (TNF)-α/CD206 and inducible nitric oxide synthase (iNOS)/CD206 ratios) and the upregulation of the pro-osteoclastogenic markers tartrate-resistant acid phosphatase (TRAP) and receptor activator of nuclear factor kappa-Β (RANK). Neutralization of IL-6 in the osteocytic secretome attenuated macrophage inflammatory gene overexpression, underscoring IL-6’s critical role in this regulatory axis. Our findings reveal that a high-glucose environment triggers osteocytic dysregulation of PTH1R-mediated signaling pathways, amplifying inflammatory and osteoclastogenic activity in bone via IL-6. This osteocyte–macrophage crosstalk may contribute to the increased bone resorption and impaired regeneration observed in diabetic bone disease. Targeting PTH1R upregulation and the IL-6 signaling pathway in osteocytes could represent a novel therapeutic approach to mitigating bone complications associated with diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bone Physiopathology Laboratory, Instituto de Medicina Molecular Aplicada (IMMA), School of Medicine, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28925 Alcorcón, Spain.
- Department of Basic Medical Sciences, School of Medicine, Universidad San Pablo-CEU, CEU Universities, Campus Monteprincipe, 28925 Alcorcón, Spain.
- Physiology and Cell Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
- Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
- Department of Orthopedic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
- Center for Musculoskeletal Disease Research, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
ORCID-Profile: Irene Tirado-Cabrera, Celia Méndez-Rodríguez, Arancha R Gortazar, Juan A Ardura
Förderung
- Ministerio de Ciencia Innovación y Universidades
- Sociedad y Fundación Española de Investigación Ósea y de Metabolismo Mineral, SEIOMM/FEIOMM
- “Ministerio de Ciencia Innovación y Universidades”
- “Sociedad y Fundación Española de Investigación Ósea y de Metabolismo Minera” SEIOMM/FEIOMM
Zitieren
APA
Tirado-Cabrera, I., Pizarro-Gomez, J., Martin-Guerrero, E., Méndez-Rodríguez, C., Bellido, T., Gortazar, A. R., & Ardura, J. A. (2026). Upregulation of Parathyroid Hormone Receptor 1 (PTH1R) in Non-Mechanostimulated Osteocytes Under High-Glucose Conditions Promotes a Macrophage Pro-Inflammatory and Osteoclastogenic Phenotype via IL-6 Secretion. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041677
Vancouver
Tirado-Cabrera I, Pizarro-Gomez J, Martin-Guerrero E, Méndez-Rodríguez C, Bellido T, Gortazar AR, et al. Upregulation of Parathyroid Hormone Receptor 1 (PTH1R) in Non-Mechanostimulated Osteocytes Under High-Glucose Conditions Promotes a Macrophage Pro-Inflammatory and Osteoclastogenic Phenotype via IL-6 Secretion. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041677
BibTeX
@article{TiradoCabrera2026,
author = {Tirado-Cabrera, Irene and Pizarro-Gomez, Joan and Martin-Guerrero, Eduardo and Méndez-Rodríguez, Celia and Bellido, Teresita and Gortazar, Arancha R and Ardura, Juan A},
title = {Upregulation of Parathyroid Hormone Receptor 1 (PTH1R) in Non-Mechanostimulated Osteocytes Under High-Glucose Conditions Promotes a Macrophage Pro-Inflammatory and Osteoclastogenic Phenotype via IL-6 Secretion},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27041677}
}
EUVIMED